Alnylam Pharmaceuticals
ALNY
#645
Rank
C$44.22 B
Marketcap
$342.84
Share price
-1.87%
Change (1 day)
32.41%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company